Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | C21H26N2O |
| Molecular Weight | 322.4439 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
CC(=O)N(C1CCN(CCC2=CC=CC=C2)CC1)C3=CC=CC=C3
InChI
InChIKey=FYIUUQUPOKIKNI-UHFFFAOYSA-N
InChI=1S/C21H26N2O/c1-18(24)23(20-10-6-3-7-11-20)21-13-16-22(17-14-21)15-12-19-8-4-2-5-9-19/h2-11,21H,12-17H2,1H3
| Molecular Formula | C21H26N2O |
| Molecular Weight | 322.4439 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
Approval Year
Targets
| Primary Target | Pharmacology | Condition | Potency |
|---|---|---|---|
Target ID: CHEMBL233 Sources: https://www.ncbi.nlm.nih.gov/pubmed/30242482 |
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 21:29:28 GMT 2025
by
admin
on
Mon Mar 31 21:29:28 GMT 2025
|
| Record UNII |
6DZ28538KS
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Preferred Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
WIKIPEDIA |
Designer-drugs-Acetylfentanyl
Created by
admin on Mon Mar 31 21:29:28 GMT 2025 , Edited by admin on Mon Mar 31 21:29:28 GMT 2025
|
||
|
DEA NO. |
9821
Created by
admin on Mon Mar 31 21:29:28 GMT 2025 , Edited by admin on Mon Mar 31 21:29:28 GMT 2025
|
||
|
WIKIPEDIA |
List_of_fentanyl_analogues
Created by
admin on Mon Mar 31 21:29:28 GMT 2025 , Edited by admin on Mon Mar 31 21:29:28 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
1269979
Created by
admin on Mon Mar 31 21:29:28 GMT 2025 , Edited by admin on Mon Mar 31 21:29:28 GMT 2025
|
PRIMARY | |||
|
ACETYLFENTANYL
Created by
admin on Mon Mar 31 21:29:28 GMT 2025 , Edited by admin on Mon Mar 31 21:29:28 GMT 2025
|
PRIMARY | |||
|
DTXSID80186275
Created by
admin on Mon Mar 31 21:29:28 GMT 2025 , Edited by admin on Mon Mar 31 21:29:28 GMT 2025
|
PRIMARY | |||
|
SUB180510
Created by
admin on Mon Mar 31 21:29:28 GMT 2025 , Edited by admin on Mon Mar 31 21:29:28 GMT 2025
|
PRIMARY | |||
|
6DZ28538KS
Created by
admin on Mon Mar 31 21:29:28 GMT 2025 , Edited by admin on Mon Mar 31 21:29:28 GMT 2025
|
PRIMARY | |||
|
3258-84-2
Created by
admin on Mon Mar 31 21:29:28 GMT 2025 , Edited by admin on Mon Mar 31 21:29:28 GMT 2025
|
PRIMARY | |||
|
527015
Created by
admin on Mon Mar 31 21:29:28 GMT 2025 , Edited by admin on Mon Mar 31 21:29:28 GMT 2025
|
PRIMARY | |||
|
100000166398
Created by
admin on Mon Mar 31 21:29:28 GMT 2025 , Edited by admin on Mon Mar 31 21:29:28 GMT 2025
|
PRIMARY | |||
|
ACETYLFENTANYL
Created by
admin on Mon Mar 31 21:29:28 GMT 2025 , Edited by admin on Mon Mar 31 21:29:28 GMT 2025
|
PRIMARY | Acetylfentanyl was discovered at the same time as fentanyl itself and had only rarely been encountered on the illicit market in the late 1980s. However, in 2013, Canadian police seized 3 kilograms of acetylfentanyl. As a μ-opioid receptor agonist, acetylfentanyl may serve as a direct substitute for heroin or other opioids. Side effects of fentanyl analogs are similar to those of fentanyl itself, which include itching, nausea and potentially serious respiratory depression, which can be life-threatening. |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
SALT/SOLVATE -> PARENT | |||
|
|
SALT/SOLVATE -> PARENT |
|
||
|
TARGET -> AGONIST |
BINDING
Ki
|
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
PARENT -> IMPURITY |
CHROMATOGRAPHIC PURITY (HPLC/UV)
USP
|
||
|
PARENT -> IMPURITY |
CHROMATOGRAPHIC PURITY (HPLC/UV)
USP
|
||
|
PARENT -> IMPURITY |
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
|
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
ACTIVE MOIETY |
ED50(mg/kg) = 0.021, LD50(mg/kg) = 9.3, Potency ratio to morphine = 15.7, Potency ratio to fentanyl = 0.29
|